David Swope

1.6k total citations
25 papers, 1.2k citations indexed

About

David Swope is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Swope has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Swope's work include Neurological disorders and treatments (15 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). David Swope is often cited by papers focused on Neurological disorders and treatments (15 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). David Swope collaborates with scholars based in United States, Switzerland and Canada. David Swope's co-authors include Jack J. Chen, Khashayar Dashtipour, Jen‐Ping Chen, Glenn L. Radice, Jifen Li, William G. Ondo, Lan Cheng, Matthew Brodsky, David A. Grimes and Eliane J. Müller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular and Cellular Biology and Neurology.

In The Last Decade

David Swope

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Swope United States 18 573 313 194 154 136 25 1.2k
Silvana Tesei Italy 17 946 1.7× 292 0.9× 126 0.6× 99 0.6× 35 0.3× 24 1.6k
Tomas Odergren Sweden 18 644 1.1× 302 1.0× 266 1.4× 49 0.3× 45 0.3× 35 1.6k
Khashayar Dashtipour United States 24 918 1.6× 590 1.9× 232 1.2× 32 0.2× 73 0.5× 70 1.7k
James R. Howard United States 13 440 0.8× 138 0.4× 85 0.4× 64 0.4× 83 0.6× 26 997
Sven Pålhagen Sweden 17 803 1.4× 316 1.0× 178 0.9× 22 0.1× 80 0.6× 32 1.3k
Hyung D. Chung United States 21 361 0.6× 418 1.3× 417 2.1× 72 0.5× 21 0.2× 33 1.3k
Mami Takemoto Japan 18 267 0.5× 76 0.2× 245 1.3× 64 0.4× 29 0.2× 118 981
John M. Bertoni United States 19 777 1.4× 333 1.1× 269 1.4× 18 0.1× 27 0.2× 67 1.4k
R. Horowski Germany 19 365 0.6× 437 1.4× 213 1.1× 32 0.2× 101 0.7× 70 1.2k
Renpei Sengoku Japan 17 600 1.0× 206 0.7× 146 0.8× 50 0.3× 13 0.1× 52 1.1k

Countries citing papers authored by David Swope

Since Specialization
Citations

This map shows the geographic impact of David Swope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Swope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Swope more than expected).

Fields of papers citing papers by David Swope

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Swope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Swope. The network helps show where David Swope may publish in the future.

Co-authorship network of co-authors of David Swope

This figure shows the co-authorship network connecting the top 25 collaborators of David Swope. A scholar is included among the top collaborators of David Swope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Swope. David Swope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kramer, Joseph, et al.. (2021). Enabled/VASP is required to mediate proper sealing of opposing cardioblasts during Drosophila dorsal vessel formation. Developmental Dynamics. 250(8). 1173–1190. 3 indexed citations
3.
Ramdhani, Ritesh, Amar Patel, David Swope, & Brian H. Kopell. (2015). Early Use of 60 Hz Frequency Subthalamic Stimulation in Parkinson’s Disease: A Case Series and Review. Neuromodulation Technology at the Neural Interface. 18(8). 664–669. 40 indexed citations
4.
Swope, David, et al.. (2014). Cdc42 is required in a genetically distinct subset of cardiac cells during Drosophila dorsal vessel closure. Developmental Biology. 392(2). 221–232. 13 indexed citations
5.
Swope, David, Jifen Li, & Glenn L. Radice. (2012). Beyond cell adhesion: The role of armadillo proteins in the heart. Cellular Signalling. 25(1). 93–100. 26 indexed citations
6.
Chen, Jack J., William G. Ondo, Khashayar Dashtipour, & David Swope. (2012). Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature. Clinical Therapeutics. 34(7). 1487–1504. 132 indexed citations
7.
Swope, David, Jifen Li, Eliane J. Müller, & Glenn L. Radice. (2012). Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability. genesis. 50(10). 717–727. 8 indexed citations
8.
Brodsky, Matthew, David Swope, & David A. Grimes. (2012). Diffusion of Botulinum Toxins. Tremor and Other Hyperkinetic Movements. 2(0). 2–2. 41 indexed citations
9.
Li, Jifen, et al.. (2011). Cardiac Tissue-Restricted Deletion of Plakoglobin Results in Progressive Cardiomyopathy and Activation of β-Catenin Signaling. Molecular and Cellular Biology. 31(6). 1134–1144. 102 indexed citations
10.
Brodsky, Matthew, David Swope, & David A. Grimes. (2011). Diffusion of Botulinum Toxins. SHILAP Revista de lepidopterología. 2. 44 indexed citations
11.
Chen, Jack J., David Swope, Khashayar Dashtipour, & Kelly E. Lyons. (2009). Transdermal Rotigotine: A Clinically Innovative Dopamine‐Receptor Agonist for the Management of Parkinson's Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(12). 1452–1467. 52 indexed citations
12.
Swope, David & Richard L. Barbano. (2008). Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. Neurologic Clinics. 26. 54–65. 32 indexed citations
13.
Chen, Jack J. & David Swope. (2007). Pharmacotherapy for Parkinson's Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(12P2). 161S–173S. 70 indexed citations
14.
Chen, Jen‐Ping, David Swope, & Khashayar Dashtipour. (2007). Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease. Clinical Therapeutics. 29(9). 1825–1849. 168 indexed citations
15.
Chen, Jack J., et al.. (2006). Update on Apomorphine for the Rapid Treatment of Hypomobility (“Off”) Episodes in Parkinson's Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(6). 840–852. 12 indexed citations
16.
Chen, Jack J. & David Swope. (2005). Clinical Pharmacology of Rasagiline: A Novel, Second‐Generation Propargylamine for the Treatment of Parkinson Disease. The Journal of Clinical Pharmacology. 45(8). 878–894. 144 indexed citations
17.
Swope, David. (2004). Rapid treatment of “wearing off” in Parkinson’s disease. Neurology. 62(6_suppl_4). S27–31. 28 indexed citations
18.
Chen, Jack J. & David Swope. (2003). Essential Tremor: Diagnosis and Treatment. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(9). 1105–1122. 32 indexed citations
19.
Walker, Ruth H., Fabio Danisi, David Swope, et al.. (2000). Intrathecal baclofen for dystonia: Benefits and complications during six years of experience. Movement Disorders. 15(6). 1242–1247. 61 indexed citations
20.
Lévesque, Martin, et al.. (1999). Subthalamic Stimulation in Parkinson’s Disease. Stereotactic and Functional Neurosurgery. 72(2-4). 170–173. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Tesei Breakdown of academic impact, for papers by Tomas Odergren Breakdown of academic impact, for papers by Khashayar Dashtipour Breakdown of academic impact, for papers by James R. Howard Breakdown of academic impact, for papers by Sven Pålhagen Breakdown of academic impact, for papers by Hyung D. Chung Breakdown of academic impact, for papers by Mami Takemoto Breakdown of academic impact, for papers by John M. Bertoni Breakdown of academic impact, for papers by R. Horowski Breakdown of academic impact, for papers by Renpei Sengoku
Rankless by CCL
2026